Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Dec;27(4):1008-17.
doi: 10.1037/a0029857. Epub 2012 Sep 3.

The natural history of cognitive decline in Alzheimer's disease

Robert S Wilson  1 , Eisuke Segawa, Patricia A Boyle, Sophia E Anagnos, Loren P Hizel, David A Bennett
Affiliations

The natural history of cognitive decline in Alzheimer's disease

Robert S Wilson et al. Psychol Aging. 2012 Dec.

Abstract

The study aim was to describe the temporal course of cognitive decline in Alzheimer's disease (AD). We selected 226 persons from 2 longitudinal clinical-pathological studies who were cognitively healthy at baseline, followed at least 4 years (M = 10.2, SD = 3.5), and clinically diagnosed with AD at some point during follow-up. Each evaluation included a battery of 17 cognitive tests from which a previously established composite measure of global cognition was derived. In those who died, a uniform neuropathologic examination established the pathological diagnoses of Alzheimer's disease and other common conditions that impair cognition. Mixed-effects models with 2 change points were used to assess trajectories of cognitive decline. In the main analysis, there was no change in cognitive function until a mean of 7.5 years before dementia was diagnosed (95% confidence interval [CI]: -8.3, -6.7). The global cognitive measure declined a mean of 0.087-unit per year (95% CI: -0.099, -0.073) until a mean of 2.0 years before the diagnosis (95% CI: -2.2, -1.7) when it increased more than 4-fold to a mean loss of 0.370-unit per year (95% CI: -0.417, -0.334). Of 126 individuals who died and underwent autopsy, 101 (80%) met pathologic criteria for AD, of whom 67 had at least one other pathologic condition. Pathologic measures of AD and cerebral infarction were not strongly related to cognitive trajectories. The results indicate that cognitive decline in AD begins many years before dementia is diagnosed and accelerates during the course of the disease.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Crude paths of change in global cognition (thin black lines) and the mean path predicted by the one (thick dashed line) and two (thick solid line) change point models.
Figure 2
Figure 2
Crude data points (open circles) and paths of cognitive change predicted by the model for 8 individuals with pathologic AD and no other pathologic conditions (randomly selected from 34) arranged in order of AD pathologic burden. The predicted path reflects both group means and person specific deviations from those means.
Figure 3
Figure 3
Crude data points (open circles) and paths of cognitive change predicted by the model for 8 individuals with pathologic AD and 1 (upper 4 plots in order of AD pathologic burden) or >1 (lower 4 plots in order of AD pathologic burden) cerebral infarcts (randomly selected from 27). The predicted path reflects both group means and person specific deviations from those means.
Figure 4
Figure 4
Crude data points (open circles) and paths of cognitive change predicted by the model for 8 individuals without pathologic AD or other pathologic conditions arranged in order of AD pathologic burden. The predicted path reflects both group means and person specific deviations from those means.
See this image and copyright information in PMC

References

    1. Amieva H, LeGoff M, Millet X, Orgogozo JM, Pérés K, Barberger-Gateau P, Jacqmin-Gadda H, Dartigues JF. Prodromal Alzheimer's disease: Successive emergence of clinical symptoms. Annals of Neurology. 2008;64:492–498. - PubMed
    1. Bäckman L, Small BJ, Fratiglioni L. Stability of the preclinical episodic memory deficit in Alzheimer's disease. Brain. 2001;124:96–102. - PubMed
    1. Bennett DA, Schneider JA, Aggarwal NT, Arvanitakis Z, Shah RC, Kelly JF, Fox JH, Cochran EJ, Arends D, Treinkman AD, Wilson RS. Decision rules guiding the clinical diagnosis of Alzheimer's disease in two community-based cohort studies compared to standard practice in a clinic-based cohort study. Neuroepidemiology. 2006;27:169–176. - PubMed
    1. Bennett DA, Schneider JA, Bienias JL, Evans DA, Wilson RS. Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions. Neurology. 2005;64:834–841. - PubMed
    1. Bennett DA, Schneider JA, Buchman AS, Mendes de Leon C, Bienias JL, Wilson RS. The Rush Memory and Aging Project: Study design and baseline characteristics of the study cohort. Neuroepidemiology. 2005;25:163–175. - PubMed

Publication types